News About: Pharm. Industry


Il Dong celebrated the 63th anniversary of company inauguration.

Il Dong Pharmaceutical Co. (CEO: Lee Kum-ki) took the 63 anniversary ceremony of the company inauguration at the company auditorium on May 4, thereby ensuring this year's target to fulfil for leaping up to be of the s...

EC approves Velcade for multiple myeloma treatment

The European Commission issued on April 27 a positive decision for Velcade (bortezomib) injection, a new treatment for multiple myeloma, a form of blood cancer. A single license has been granted to market Velcade ...

Domestic pharmaceutical firms mull product restructuring

A number of domestic pharmaceutical firms are gearing up to concentrate their efforts on profit-making items via intensive product restructuring program designed to eliminate some items with little marketability, lowe...

Korea develops artificial bone for clinical trials

The artificial bone, developed by Daewoon Pharm and Bioalpha Co. for the first time in Korea, has obtained official approval from the Korea Food and Drug Administration for clinical trials. This trials for 126 pati...

Bayer, GSK to start multinational comparative trials between Levitra and Cialis

Bayer Korea and GSK said they are pressing ahead with multinational comparative trials to examine the therapeutic efficacy of both Levitra (vardenafil HCl) and Cialis (tadalafil...

Use of copy product hurts Korea's drug image

Instead of generic drugs, the frequent use of copy products at some quarters may give a negative impact to the quality of locally-manufactured products and image of domestic pharmaceutical industry, and thus all parti...

Hami's Oraxol, novel oral formulation of paclitaxel, inhibits neointimal hyperplasia in rat model

Hanmi Pharm said recently that Oraxol, oral formulations of paclitaxol, provide an effective means of inhibiting proliferative response to vascular injury in rat treated at a lower dose (5mg/kg), according to the rece...

Handok-Aventis to support 31 hospitals for free osteoporosis tests.

Handok-Aventis (President: Kim Young-jin) announced to put a nationwide event under the theme of "Osteoporosis test campaign for mothers and daughters together" through 31 general hospitals across the nation during Ma...

Enbrel to be launched in Korea

Wyeth Korea said it plans to launch Enbrel (etanercept) for the treatment of rheumatoid arthritis (RA) from May 29, as the third country in Asia following Australia and Taiwan. Enbrel is the only biologic therapy a...

Insecticide makers focus on double market sectors in 2004

Korea's major insecticide makers plan to increase their market share this year to bolster profitability through banner advertisements targeting both pharmacy and discount stores, which will greatly affect sales of who...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.